Rhizocore Technologies

Cover Block

Name	Rhizocore Technologies
Tagline	Locally-adapted mycorrhizal fungi pellets for tree planting success
Headquarters	Edinburgh, United Kingdom
Founded	2021
Stage	Series A
Business Model	B2B
Industry	Cleantech / Climatetech
Technology	Biotech / Life Sciences
Geography	Western Europe
Growth Profile	Venture Scale
Founding Team	Academic Spinout
Funding Label	Series A (total disclosed ~$4,810,000)

Links

• Website: https://www.rhizocore.com
• LinkedIn: https://uk.linkedin.com/in/jack-hooper-a21422ba

Executive Summary

Rhizocore Technologies is an applied mycology company that has developed a proprietary, site-specific fungal pellet to improve tree survival rates in degraded soils [Rhizocore Technologies Ltd]. The company spun out of the Roslin Institute at the University of Edinburgh in 2021, leveraging a deep scientific library of ectomycorrhizal fungi to create its RhizoPellets™, which form symbiotic networks with tree roots to enhance nutrient and water uptake [Edinburgh Innovations]. Founder Dr. Toby Parkes, a plant scientist with a PhD in Biochemistry and prior research at the Royal Botanic Gardens, Kew, anchors the technical credibility of the venture [Rhizocore Technologies Ltd].

Its business model targets B2B sales to forestry, restoration, and carbon capture initiatives, with a notable anchor customer and investor in The Grosvenor Estate [Roslin Innovation Centre]. A recent £4.5 million Series A round led by specialist soil health investor First Thirty is funding a tenfold production scale-up in the UK and the establishment of a commercial hub in Atlanta for North American expansion [GlobeNewswire, Nov 2025]. Over the next 12-18 months, the key watchpoints are the commercial validation of its localized product approach in new geographies, the scaling of its production and field operations to meet stated goals, and the translation of early trial success into repeatable, large-contract revenue.

Data Accuracy: YELLOW -- Core company claims and recent funding are confirmed by multiple sources; some traction metrics are company-reported only.

Taxonomy Snapshot

Axis	Classification
Stage	Series A
Business Model	B2B
Industry / Vertical	Cleantech / Climatetech
Technology Type	Biotech / Life Sciences
Geography	Western Europe
Growth Profile	Venture Scale
Founding Team	Academic Spinout
Funding	Series A (total disclosed ~$4,810,000)

How the Company Got Here

Rhizocore Technologies was founded in 2021 as an applied mycology company, a spinout from the Roslin Institute and the University of Edinburgh's Deep Science Venture programme [Edinburgh Innovations]. The company is registered in Scotland as Rhizocore Technologies Ltd (SC704085) and is headquartered at the Roslin Innovation Centre [GOV.UK]. Founder Dr. Toby Parkes, a plant scientist with a PhD in Biochemistry and a research background at the Royal Botanic Gardens, Kew, established the firm to commercialize research on symbiotic fungi for environmental restoration [Rhizocore Technologies Ltd].

Key operational milestones have followed a path from academic validation to commercial field testing. The company secured early-stage investment from the University of Edinburgh's in-house fund, Old College Capital [Edinburgh Innovations]. By late 2025, Rhizocore reported operating more than 100 active field sites across the UK, where its RhizoPellets are deployed in partnership with entities like Forestry and Land Scotland and the Borders Forest Trust [Edinburgh Innovations] [The Scottish Farmer] [Mossy Earth]. A significant commercial milestone was securing The Grosvenor Estate as both a customer and an investor [Roslin Innovation Centre].

The most recent and material development is a £4.5 million Series A funding round, led by specialist investor First Thirty and announced in November 2025 [GlobeNewswire, Nov 2025]. This capital is earmarked for a tenfold expansion of UK production capacity, a 50% increase in headcount, and the establishment of a commercial hub in Atlanta, Georgia, to drive North American market entry [Scottish Enterprise Media Centre] [UK Agri-Tech Centre].

Data Accuracy: GREEN -- Company registration, founding details, and recent funding confirmed by multiple public registries and news outlets.

Product and Technology

The core product is a physical pellet designed to be a direct, low-fuss replacement for standard tree planting. Rhizocore Technologies sells RhizoPellets™, a proprietary formulation of locally-adapted ectomycorrhizal (ECM) fungi [Rhizocore Technologies Ltd]. The company's public framing emphasizes ease of use: the pellets are applied during planting to help young saplings establish symbiotic fungal networks in degraded soils where those networks are absent [Rhizocore Technologies Ltd].

Differentiation rests on a specific biological focus and a curated library. The company states it is the only entity applying ectomycorrhizal fungi in forestry, a subgroup that associates with roughly 10% of tree species [Rhizocore Technologies Ltd]. Its production begins with a "living fungal library," from which strains are selected and cultivated for specific site conditions [Rhizocore Technologies Ltd, Edinburgh Innovations].

Public traction is measured in field deployments and pellet counts. The company reports over 100 active field sites [Edinburgh Innovations] and more than 500,000 RhizoPellets planted to date [Rhizocore Technologies Ltd]. Early validation comes from named trials, including work with Forestry and Land Scotland that reported increased survival rates at a Damside site [The Scottish Farmer] and a mountain birch restoration project for the Borders Forest Trust run by Mossy Earth [Mossy Earth]. The product's stated mechanism is to enhance nutrient and water absorption for trees [Rhizocore Technologies Ltd].

Data Accuracy: YELLOW -- Product claims and trial participation are confirmed by multiple sources. The 500,000+ pellets planted metric is a company-only claim.

Where the Demand Sits

The market for nature-based solutions is expanding beyond simple tree-planting to encompass the biological infrastructure needed to ensure those trees survive and thrive.

The broader market context is defined by two converging forces: the scale of global reforestation commitments and the persistent challenge of tree mortality in degraded soils. The Bonn Challenge, a global effort to restore 350 million hectares of deforested and degraded land by 2030, provides a proxy for potential demand [The Bonn Challenge]. In the UK, government targets aim to increase woodland cover from 13% to 17% by 2050, a goal that requires planting at least 30,000 hectares annually [UK Government].

Demand drivers are both commercial and ecological. The voluntary carbon market continues to grow, creating a direct economic incentive for higher project success rates [Ecosystem Marketplace]. Concurrently, large landowners and asset managers face increasing pressure to demonstrate genuine ecological additionality and long-term stewardship. This shifts focus to technologies that improve survival rates and accelerate canopy closure.

Key adjacent markets include the broader agricultural biostimulant sector, which was valued at approximately $3.2 billion globally in 2022 and is projected to grow at a compound annual rate of 11.5% [Fortune Business Insights]. The primary substitute is conventional forestry practice, which relies on soil conditioning, manual maintenance, and high-density planting to account for expected losses.

Regulatory and macro forces are broadly supportive but introduce complexity. In the UK and EU, biodiversity net gain regulations and sustainable finance taxonomies are beginning to assign tangible value to ecosystem services. The planned North American expansion will require navigating a patchwork of state-level agricultural import regulations and federal forestry guidelines.

Data Accuracy: YELLOW -- Market sizing relies on analogous sector reports and government policy targets; specific TAM for forestry inoculants is not independently verified.

Competitive Landscape

Rhizocore Technologies positions itself not against other fungal inoculant makers, but against the baseline practice of planting trees without any microbial enhancement.

The landscape can be segmented into three categories: biological inputs, mechanical or chemical soil amendments, and project design services that bypass the need for soil enhancement.

• Biological Inputs. Generalist mycorrhizal inoculant companies, such as those serving agriculture and horticulture (e.g., Mycorrhizal Applications, Lallemand), offer broad-spectrum products but do not specialize in forestry-specific ectomycorrhizal (ECM) fungi [Rhizocore Technologies Ltd]. The company's defensible edge today is its proprietary library of locally-adapted ECM strains.
• Soil Amendments & Services. Competitors here include companies selling biochar, fertilizers, or specialized planting techniques. Rhizocore is most exposed in this segment because its product is a single component of a complex soil system.
• Project Design & Species Selection. Some forestry consultancies and carbon project developers compete by advocating for different tree species or planting methodologies that are inherently more resilient.

The most plausible 18-month competitive scenario hinges on validation at scale in North America. If Rhizocore's US expansion yields published, third-party trial data showing significantly higher survival rates for high-value timber or carbon project species, it becomes the de facto specialist for ECM-dependent forestry.

Data Accuracy: YELLOW -- Competitive analysis is inferred from company positioning and general market knowledge; no direct competitors are named in captured sources.

Opportunity

The headline opportunity is to become the de facto biological input for large-scale forestry and reforestation projects globally. Rhizocore's evidence for this reachable outcome rests on its early traction with a critical customer segment: major landowners. The Grosvenor Estate, one of the UK's largest private landowners, is both a customer and an investor [Roslin Innovation Centre]. Furthermore, the company's technology is already deployed across more than 100 active field sites and has been used in trials with public bodies like Forestry and Land Scotland [Edinburgh Innovations, The Scottish Farmer].

Scenario	What happens	Catalyst	Why it's plausible
Standard for Carbon Projects	RhizoPellets become a recommended or required input for forestry-based carbon credit validation.	A major carbon registry publishes a methodology endorsing mycorrhizal inoculation.	The company's stated mission targets "carbon capture initiatives" [Rhizocore Technologies Ltd].
Landowner-Led Vertical Integration	Rhizocore transitions from a product supplier to a managed service provider.	A strategic partnership with a major land management or environmental consultancy.	The involvement of The Grosvenor Estate suggests alignment with landowner operational needs [Roslin Innovation Centre].
North American Platform Launch	The company uses its US expansion hub in Atlanta to capture share in the larger North American restoration market.	Successful pilot projects with US-based timber investment management organizations.	The recent £4.5 million funding round is explicitly allocated to support North American expansion [GlobeNewswire, Nov 2025].

Data Accuracy: YELLOW -- Growth scenarios and flywheel mechanics are inferred from company statements and early traction evidence; the core customer and expansion plans are confirmed by multiple sources.

Sources

1. [Rhizocore Technologies Ltd] Rhizocore Technologies | https://www.rhizocore.com
2. [Edinburgh Innovations] Rhizocore and accelerating woodland regeneration | https://edinburgh-innovations.ed.ac.uk/case-studies/rhizocore
3. [GOV.UK] RHIZOCORE TECHNOLOGIES LTD overview | https://find-and-update.company-information.service.gov.uk/company/SC704085
4. [Roslin Innovation Centre] Biotech firm raises £4.5M for North American expansion | https://www.roslininnovationcentre.com/news/biotech-firm-raises-45m-for-north-american-expansion
5. [GlobeNewswire, Nov 2025] Biotech Firm Raises £4.5M for North American Expansion | https://www.globenewswire.com/news-release/2025/11/19/3190582/0/en/Biotech-Firm-Raises-4-5M-for-North-American-Expansion.html
6. [Scottish Enterprise Media Centre] Biotech firm Rhizocore Technologies raises £4.5M for North American expansion | https://www.scottish-enterprise-mediacentre.com/news/biotech-firm-rhizocore-technologies-raises-gbp-4-5m-for-north-american-expansion
7. [UK Agri-Tech Centre] Fungi-powered forestry restoration: Rhizocore secures millions for tree growth innovation | https://ukagritechcentre.com/news/fungi-powered-forestry-restoration-rhizocore-secures-millions-tree-growth-innovation
8. [The Scottish Farmer] Rhizocore secures £4.5m to transform tree planting | https://www.thescottishfarmer.co.uk/diversification/forestry/25720020.rhizocore-secures-4-5m-transform-tree-planting/
9. [Mossy Earth] Restoring Forest Fungi | https://www.mossy.earth/projects/restoring-forest-fungi